Amag Pharmaceuticals names new board member

Mr Perez is currently the executive vice president and COO at Cubist Pharmaceuticals, and is responsible for commercial operations, business development, technical operations, the Cubicin development team and information technology.

Mr Perez holds an MBA from The Anderson School at University of California, Los Angeles and a BS from California State University, Los Angeles.

Brian Pereira, president and CEO of Amag Pharmaceuticals, said: “Rob’s commercial and operational experience will be particularly helpful to us as we plan for the successful launch of Feraheme. With over 20 years of pharmaceutical experience, Rob’s wealth of knowledge and expertise will be a valuable addition to our board.”